What is the market doing?
What the tape says about VRTX
Vertex Pharmaceuticals is +42% over the past year while the S&P 500 is +23%: 19 points ahead of the market.
+42%
1-year return · S&P 500 +23%
- vs 200-day average
- +20%
vs 200-day average · a clear uptrend
- RSI (14)
- 71
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −1.0%
Below its 52-week high
Details›
- Last close2026-08-26
- $547.27
- 1 monthS&P 500 +3.7%
- +16%
- 1 yearS&P 500 +23%
- +42%
- 5 yearsS&P 500 +87%
- +171%
- vs 50-day average$482.17
- +14%
- 52-week high
- $553.04
- 52-week low
- $366.54
- Annualised volatility
- 32%
| Year | Return |
|---|---|
| 2026 (year to date) | +21% |
| 2025 | +13% |
| 2024 | −1.0% |
| 2023 | +41% |
| 2022 | +32% |
| 2021 | −7.1% |
| 2020 | +7.9% |
| 2019 | +32% |
| 2018 | +11% |
| 2017 | +103% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 9 of 10 | +9.1% |
| Feb | 10 | 3 of 10 | −1.3% |
| Mar | 10 | 6 of 10 | +3.6% |
| Apr | 10 | 6 of 10 | +0.87% |
| May | 10 | 5 of 10 | +1.4% |
| Jun | 10 | 9 of 10 | +4.6% |
| Jul | 11 | 7 of 11 | +2.7% |
| Aug | 11 | 7 of 11 | +1.4% |
| Sep | 10 | 3 of 10 | −3.0% |
| Oct | 10 | 6 of 10 | −1.2% |
| Nov | 10 | 7 of 10 | +3.6% |
| Dec | 10 | 5 of 10 | +0.23% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.